Image pharmaphorum Editor R&D JP Morgan 2023 – Day 2 Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase. R&D JP Morgan 2023 - Day 1 We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning. R&D JP Morgan 2023 For most people, the name “JP Morgan” means bankers and investors. Digital The importance of AI literacy in life sciences The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology. Load more results
R&D JP Morgan 2023 – Day 2 Tuesday brings the on-site part of Fierce’s JPM event as well as day 2 of the Informa Biotech Showcase.
R&D JP Morgan 2023 - Day 1 We’re preparing to start JP Morgan week with a busy day Monday, with day 1 of the Informa Biotech Showcase, including a dedicated mini-event on Cell and Gene Therapy in the morning.
Digital The importance of AI literacy in life sciences The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.